We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
-7.23%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$92.4M
AUM Growth
-$24.2M
Cap. Flow
-$14.9M
Cap. Flow %
-16.14%
Top 10 Hldgs %
40.1%
Holding
400
New
–
Increased
65
Reduced
21
Closed
286

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$647K
2
HBAN icon
Huntington Bancshares
HBAN
+$175K
3
DHR icon
Danaher
DHR
+$142K
4
U icon
Unity
U
+$108K
5
XYZ
Block Inc
XYZ
+$105K

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$570K
2
TER icon
Teradyne
TER
+$296K
3
XYL icon
Xylem
XYL
+$293K
4
SPOT icon
Spotify
SPOT
+$234K
5
RBLX icon
Roblox
RBLX
+$233K

Sector Composition

Rank Sector Weight
1 Technology 51.09%
2 Healthcare 13.04%
3 Consumer Discretionary 9.43%
4 Financials 7.08%
5 Communication Services 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.04T
$883K 0.96%
3,085
+2
+0.1% +$515
TSLA icon
27
Tesla
TSLA
$1.27T
$808K 0.87%
2,250
+165
+8% +$51.4K
MCD icon
28
McDonald's
MCD
$195B
$800K 0.87%
3,235
+3
+0.1% +$747
LRCX icon
29
Lam Research
LRCX
$385B
$794K 0.86%
14,770
+150
+1% +$8.73K
TMO icon
30
Thermo Fisher Scientific
TMO
$214B
$783K 0.85%
1,326
– –
CSCO icon
31
Cisco
CSCO
$479B
$775K 0.84%
13,912
+321
+2% +$18.2K
DIS icon
32
Walt Disney
DIS
$177B
$748K 0.81%
5,456
+595
+12% +$86K
CRWD icon
33
CrowdStrike
CRWD
$214B
$722K 0.78%
12,720
+120
+1% +$5.59K
ZS icon
34
Zscaler
ZS
$26.1B
$720K 0.78%
2,987
-25
-0.8% -$6.14K
BA icon
35
Boeing
BA
$190B
$703K 0.76%
3,673
+320
+10% +$64.2K
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$689K 0.75%
5,818
-35
-0.6% -$4.37K
AMZN icon
37
Amazon
AMZN
$2.94T
$681K 0.74%
4,180
– –
V icon
38
Visa
V
$688B
$664K 0.72%
2,995
-50
-2% -$10.8K
NXPI icon
39
NXP Semiconductors
NXPI
$58.3B
$660K 0.71%
3,571
+175
+5% +$34.5K
LOW icon
40
Lowe's Companies
LOW
$123B
$654K 0.71%
3,239
+19
+0.6% +$4.37K
PAYX icon
41
Paychex
PAYX
$42.1B
$654K 0.71%
4,797
+46
+1% +$5.65K
JNJ icon
42
Johnson & Johnson
JNJ
$621B
$648K 0.7%
3,661
+6
+0.2% +$1.02K
XOM icon
43
ExxonMobil
XOM
$628B
$641K 0.69%
7,768
-235
-3% -$18.3K
CVS icon
44
CVS Health
CVS
$126B
$640K 0.69%
6,324
+516
+9% +$54.2K
PG icon
45
Procter & Gamble
PG
$341B
$634K 0.69%
4,152
+6
+0.1% +$939
SBUX icon
46
Starbucks
SBUX
$121B
$623K 0.67%
6,856
-1,301
-16% -$123K
TGT icon
47
Target
TGT
$67.1B
$623K 0.67%
2,939
+1
+0% +$216
EXPE icon
48
Expedia Group
EXPE
$38.4B
$615K 0.67%
3,148
+432
+16% +$80.8K
U icon
49
Unity
U
$15.5B
$611K 0.66%
6,168
+1,043
+20% +$108K
SWKS icon
50
Skyworks Solutions
SWKS
$10.1B
$601K 0.65%
4,513
+1
+0% +$140
1
2
3 4 5

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM

KRS Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, KRS Capital Management held 400 positions worth $92.4M, down 21% from $117M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

KRS Capital Management withdrew a net $14.9M in Q1 2022, closing 286 positions and reducing 21 holdings. Its most notable exit was Xilinx Inc, an estimated $570K position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, KRS Capital Management added an estimated $647K to Advanced Micro Devices.

  • KRS Capital Management added most to Advanced Micro Devices in Q1 2022, an estimated $647K increase.
  • KRS Capital Management's biggest Q1 2022 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $139K.
  • KRS Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $570K.
  • KRS Capital Management's ten largest holdings make up 40% of its $92.4M portfolio in Q1 2022.
  • KRS Capital Management opened 0 new positions and closed 286 in Q1 2022.
  • KRS Capital Management's portfolio value fell 21% quarter-over-quarter to $92.4M.

Based on KRS Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.